The Revolution of CAR-NK Therapy: Transforming Disease Treatment
In the ever-evolving landscape of medical innovation, one breakthrough stands out—a transformative approach known as CAR-NK therapy. This groundbreaking development has the potential to revolutionize disease treatment, offering a safer and more effective solution for patients. Join us as we delve into the five pivotal aspects of CAR-NK therapy, reshaping the future of medical care.
CAR-NK Therapy: Why is it a Game-Changer in Disease Treatment
1. Enhanced Safety and Versatility:
At its core, CAR-NK therapy represents a monumental shift in the treatment of various medical conditions. What sets it apart is its enhanced safety and versatility. Unlike its predecessor, CAR-T therapy, which uses the patient’s own T cells, CAR-NK cells can be derived from healthy donors or stem cells. This distinction significantly reduces the risk of complications, including graft-versus-host disease and cytokine release syndrome, which can sometimes accompany CAR-T therapy. Moreover, CAR-NK cells can be stored and used off-the-shelf, making them more readily available for patients in need.
2. Effective Against a Wide Range of Diseases:
The versatility of CAR-NK therapy extends to its effectiveness against a diverse spectrum of diseases. These remarkable cells possess the ability to target multiple antigens present on various cell types. From hematologic conditions to solid tumors, CAR-NK therapy demonstrates remarkable efficacy. Furthermore, it has the potential to counteract the mechanisms employed by cells to evade the immune system, such as immunosuppression and antigen loss.
3. Cost-Efficiency and Speedy Production:
Another compelling aspect of CAR-NK therapy is its cost-efficiency and rapid production. In comparison to the complex and personalized approach required for CAR-T therapy, CAR-NK cells can be manufactured on a larger scale. This streamlined production process significantly lowers costs, making this innovative therapy more accessible to a wider range of patients. The affordability of CAR-NK therapy brings us one step closer to a future where cutting-edge treatments are within reach for all.
4. A Thriving Field with Promising Potential:
While CAR-NK therapy is still in its early stages of clinical development, the initial results are promising and encouraging. Researchers and medical professionals worldwide are working tirelessly to unlock its full potential. Early trials have demonstrated its safety and efficacy, raising hopes for further breakthroughs in disease treatment.
CAR-NK therapy represents a monumental leap forward in disease treatment. At ISSCA.com, we are dedicated to advancing knowledge in the realm of regenerative medicine. We invite you to explore the transformative possibilities of CAR-NK therapy and its potential to reshape the future of medical care. As we journey together, you’ll discover that the horizon of possibilities in healthcare is continually expanding.
Explore our courses and international congresses at ISSCA.com to deepen your knowledge in regenerative medicine.
- Published in Blog
Beyond Boundaries: How Stem Cells Are Reshaping Organ and Tissue Transplantation
Stem Cells: Pioneers of Regeneration
Within the sacred corridors of medical advancement, a profound transformation is silently taking place, poised to reshape the very foundations of organ and tissue transplantation. Envision a realm where donor shortages and the specter of immune system rejection fade into history, and where medical horizons stretch to unprecedented frontiers. In this immersive voyage, we embark on a journey to unmask the enigmatic power of stem cells in the realm of transplantation, a journey that invites you to witness the precipice of medical progress.
The Choreography of Compatibility
Navigating the intricate choreography of compatibility between donor and recipient is one of the most formidable tasks in transplantation. The ever-watchful immune system often triggers rejection, undermining even the most meticulous transplantation endeavors. Yet, stem cells are orchestrating a symphony of change. Through ingenious techniques, researchers are tapping into stem cells’ immunomodulatory prowess, crafting an environment of harmonious coexistence between donor and recipient. This revolutionary approach not only mitigates the risks of rejection but also broadens the spectrum of viable donors.
A Symphony of Science
The harmony between stem cells and transplantation is not an untested hypothesis; it’s a symphony composed through rigorous scientific exploration. An extensive repertoire of peer-reviewed studies, gracing the pages of prestigious journals such as The Lancet and Nature Communications, underscores the potential of stem cells to elevate transplant success rates. These studies illuminate advancements spanning from refining graft survival to hastening the regeneration of vital tissues, a resounding affirmation of the transformative capabilities underpinning stem cell-driven transplantation.
Embark on a Journey of Revelation
Eager to unravel the mysteries encapsulating stem cell-powered transplantation? We extend a heartfelt invitation to embark on an illuminating expedition through our comprehensive training courses in regenerative medicine. Enrich your understanding under the tutelage of eminent experts, delving into the most recent breakthroughs, evidence-based methodologies, and clinical applications. Step into a realm where the boundaries of medical possibilities are redrawn, where your perception of transplantation is enriched, and where you assume the mantle of a pioneer in the regenerative revolution.
The fusion of stem cells and organ transplantation isn’t confined to the realm of scientific speculation; it represents a monumental stride towards re-scripting the destinies of countless lives. As we venture into an epoch where medical accomplishments redefine our limits, the expedition becomes all the more exhilarating.
Join us at issca.us, where the convergence of science and hope awaits. Immerse yourself in the vanguard of regenerative medicine, where the transformative prowess of stem cells beckons. Together, we shall forge ahead, empowered by the symphony of possibilities, shaping a brighter, healthier future for generations to come.
- Published in Blog
Exploring the Frontier of Regenerative Medicine: Unraveling Autologous and Allogeneic Stem Cells
WEDNESDAY, 06 SEPTEMBER 2023 / PUBLISHED IN BLOG
Exploring the Frontier of Regenerative Medicine: Unraveling Autologous and Allogeneic Stem Cells
In the realm of modern medicine, a groundbreaking field has emerged, promising to reshape the way we approach healing and rejuvenation – regenerative medicine. At the heart of this revolution lie stem cells, the unsung heroes of tissue repair and regeneration. In this comprehensive exploration, we delve into the intricate differences between two crucial types of stem cells: autologous and allogeneic. Prepare to be captivated by the scientific intricacies that underpin these extraordinary cells and discover how they’re poised to redefine medical possibilities.
Autologous Stem Cells: A Personalized Touch
Imagine harnessing the power of your body’s own natural healing abilities. Autologous stem cells make this vision a reality. Derived from your own tissues – be it bone marrow, adipose tissue, or other sources – these cells hold the promise of personalized healing. The process involves harvesting the stem cells, processing them to enhance their therapeutic potential, and then reintroducing them into the body. This “self-healing” approach minimizes the risk of rejection and side effects, making autologous stem cell therapies an attractive option for many.
Scientific Precision
Autologous stem cell therapies are supported by a wealth of scientific evidence. Studies published in esteemed journals like the Journal of Translational Medicine and Stem Cell Research & Therapy have highlighted their potential in diverse applications, from musculoskeletal disorders to cardiovascular conditions. This approach holds immense promise for targeted healing while minimizing the risk of immune system complications.
Allogeneic Stem Cells: A Shared Resource for Healing
In the quest for regenerative solutions, allogeneic stem cells emerge as a game-changer. These cells are sourced from carefully screened donors and subsequently administered to patients. By tapping into a shared pool of stem cells, medical practitioners can provide a standardized treatment option that’s readily available. Allogeneic stem cells hold the potential to address a broad spectrum of conditions, offering a versatile and accessible avenue for regenerative therapies.
Scientific Validation
The science behind allogeneic stem cell therapies is compelling. Rigorous research published in renowned journals such as the Journal of Stem Cells and Development and Stem Cells Translational Medicine has underscored their efficacy in various medical scenarios. This approach not only broadens the scope of treatment but also expedites the therapeutic process, presenting an exciting frontier in regenerative medicine.
Embrace the Future with Knowledge
Intrigued by the dynamic interplay of autologous and allogeneic stem cells in regenerative medicine? We invite you to embark on a transformative journey of discovery through our comprehensive training courses. Our platform offers unparalleled insights into the latest advancements, evidence-based practices, and clinical applications of these remarkable stem cells. Guided by esteemed experts in the field, our courses provide a unique opportunity to stay at the forefront of regenerative medicine’s evolution.
As the horizon of medicine expands to encompass regenerative possibilities, autologous and allogeneic stem cells take center stage. These cellular protagonists hold the key to unlocking personalized healing and broad-spectrum rejuvenation, ushering in an era of medical advancement like never before. Join us in our mission to unravel the mysteries of regenerative medicine and explore the profound potential of stem cells. Visit issca.us today, and together, let’s embark on a journey that could reshape the landscape of healthcare for generations to come.
- Published in Blog
ISSCA Announces Its Next World Congress 2023: The Premier Regenerative Medicine Event of the Year
The International Society for Stem Cell Application (ISSCA) is excited to announce the much-anticipated World Congress 2023, further establishing its role as the primary global hub for regenerative medicine. The event is set to occur from November 10 to 12, 2023, at the esteemed Crowne Plaza Istanbul Florya Hotel in Istanbul, Turkey. Drawing on the remarkable achievements of the previous conference held at the Radisson Blu Hotel on September 23 to 26, 2022, ISSCA is prepared to exceed all predictions with this highly anticipated World Congress.
During the three-day congress, prominent physicians from across the globe will come together, offering an extensive agenda of presentations and interactive sessions. “Our ISSCA Congresses once more provide a great opportunity to disseminate this information to the physicians who need it most, and we plan to organize as many as we can before the end of the year,” says ISSCA Managing Director and CEO of Global Stem Cells Group Benito Novas about the upcoming congress.
Participants can anticipate captivating workshops, including those focused on aesthetic and clinical applications, aimed at delving into the most recent advancements within the rapidly evolving field of regenerative medicine.
In a full schedule of lectures, the congress will shed light on significant subjects such as molecular biology, innovative treatment approaches in surgical and cosmetic domains, and the latest cutting-edge technologies that have emerged in the field. In addition, the congress will explore the legal framework encompassing regenerative medicine practices on a global scale, acknowledging the varying degrees of involvement by various national governments.
This conference demonstrates ISSCA’s dedication to facilitating a transformative change from traditional healthcare methods to regenerative medicine while showcasing the most recent innovative discoveries and progress in all aspects of stem cell research.
The Crowne Plaza Istanbul Florya Hotel, known for its modern facilities and ideal location in Istanbul, Turkey, will serve as the prestigious venue for this highly anticipated event. Its comfortable and conducive environment provides the optimum platform for attendees to exchange ideas and establish new partnerships.
The ISSCA World Congress 2023 in Istanbul is a must-attend event for anyone interested in regenerative medicine. With a focus on innovation, collaboration, and knowledge exchange, the congress promises to be a transformative experience for all attendees. Whether you are a scientist, physician, or healthcare professional, this event offers an opportunity to gain valuable insights and forge new connections with like-minded individuals from around the world.
For more information about the November 10 to 12 ISSCA World Congress 2023, please visit our official website today.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.
The mission of the International Stem Cell Certification Agency (ISSCA) is to establish itself as a global leader in regenerative medicine certification, education, research, and training.
ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.
About Global Stem Cells Group:
The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.
GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
To learn more about Global Stem Cells Group, Inc.’s companies visit our website www.stemcellsgroup.com or call +1 305 560 5331
Safe Harbor Statement:
Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
- Published in News
Ozone Therapy: A Promising Alternative Treatment with Potential Benefits
MONDAY, 24 APRIL 2023 / PUBLISHED IN BLOG
Ozone therapy is a promising alternative medical treatment that has gained popularity in recent years. It involves the administration of ozone, a form of oxygen, to treat various medical conditions, ranging from chronic pain to infections. Although the scientific evidence on the effectiveness of ozone therapy remains limited, many people claim to have experienced significant health benefits from this alternative treatment. In this article, we’ll explore the potential benefits and risks of ozone therapy, as well as the latest research on this alternative medical treatment.
What is Ozone Therapy?
Ozone therapy is a safe, non-invasive, and effective alternative medical treatment that has been used for over a century. It involves the administration of ozone, a gas made up of three oxygen atoms, to the body in various forms, such as injections, insufflations, or topical applications. Ozone is a powerful oxidant that can damage cells and tissues, which can have positive or negative effects, depending on the form and amount of ozone used.
One of the key benefits of ozone therapy is its ability to improve blood circulation and oxygen delivery to the tissues, which can help reduce inflammation, support wound healing, and boost immune function. Additionally, ozone therapy is believed to have antimicrobial and antiviral properties, which may help fight infections caused by bacteria, viruses, and fungi.
Potential Benefits of Ozone Therapy
Ozone therapy has been used to treat a wide range of medical conditions, including:
- Chronic Pain: Ozone therapy may help reduce pain and inflammation in conditions such as osteoarthritis, herniated discs, and fibromyalgia.
- Infections: Ozone therapy may help fight infections caused by bacteria, viruses, and fungi, including Lyme disease, hepatitis, and HIV.
- Autoimmune Diseases: Ozone therapy may help reduce inflammation and improve immune function in conditions such as multiple sclerosis, rheumatoid arthritis, and lupus.
- Skin Conditions: Ozone therapy may help treat various skin conditions, including eczema, psoriasis, and acne, by improving blood circulation and oxygenation.
Moreover, ozone therapy is a safe and non-invasive treatment that doesn’t have the side effects commonly associated with traditional medical treatments. It’s also relatively inexpensive and can be administered in a variety of settings, including clinics, hospitals, and private practices.
Latest Research on Ozone Therapy
Although the scientific evidence on the effectiveness and safety of ozone therapy remains limited, some recent studies have suggested that ozone therapy may have potential health benefits in certain conditions.
- Immunomodulatory Properties: A study published in the Cuban journal of immunology describes the immunomodulatory properties of ozone therapy by characterizing the biological effects of ozone on immune system cells, soluble mediators, and other cell types.
- Pain Management: A 2022 review on ozone therapy in pain medicine highlights the high safety of pain treatments with ozone therapy, especially modern medical ozone generators with great precision.
- Diabetic Pain Relief: A 2020 study on systemic ozone therapy in insulin-dependent diabetic patients found that the analgesic and anti-inflammatory properties of ozone make it one of the most efficient therapeutic tools for controlling chronic pain in insulin-dependent diabetic patients.
Conclusion
Ozone therapy is a promising alternative medical treatment that has been used to treat various medical conditions. Many people claim to have experienced significant health benefits from this alternative treatment. Furthermore, ozone therapy is a safe and non-invasive treatment that doesn’t have the side effects commonly associated with traditional medical treatments.
If you’re interested in ozone therapy, make sure to do your research, ask questions, and consider this alternative medical treatment as a potential option for your health concerns. It’s important to stay informed about the latest developments in stem cell therapy. You can learn more about regenerative medicine and stem cells by enrolling in our international certification program at www.issca.us.
- Published in Blog
Personalized Regenerative Medicine: The Future of Regenerative Medicine
MONDAY, 17 APRIL 2023 / PUBLISHED IN BLOG
Regenerative medicine is a rapidly growing field that focuses on repairing or replacing damaged or diseased tissues and organs using stem cells, growth factors, and other advanced therapies. The effectiveness of this approach has been demonstrated in treating a wide range of conditions, including heart disease, diabetes, joint pain, and neurological disorders. One of the major challenges of regenerative medicine, however, is that not every patient responds to the same treatment. This is where personalized regenerative medicine comes into play.
What is Personalized Regenerative Medicine?
Personalized regenerative medicine involves tailoring treatments to meet the unique needs of each patient based on their genetic profile, lifestyle, and medical history. This approach recognizes that no two patients are the same and that a one-size-fits-all approach to regenerative medicine is not always effective.
As part of personalized regenerative medicine, advanced technologies such as genomics, proteomics, and metabolomics are used to analyze a patient’s unique biological profile. Regenerative medicine centers utilize this information to develop personalized treatment plans tailored to their individual needs and conditions, ranging from stem cell therapy to gene therapy.
Why is Personalized Regenerative Medicine the Future of Regenerative Medicine?
There are several reasons why personalized regenerative medicine is the future of regenerative medicine:
More Effective Treatments
By tailoring treatments to individual patients, personalized regenerative medicine has the potential to be much more effective than traditional one-size-fits-all approaches.
Improved Patient Outcomes
Because personalized regenerative medicine takes into account the unique needs and conditions of each patient, it has the potential to improve patient outcomes and reduce the risk of complications.
Lower Healthcare Costs
By providing more effective treatments and reducing the risk of complications, personalized regenerative medicine has the potential to lower healthcare costs in the long run.
Better Understanding of Disease
Personalized regenerative medicine involves analyzing a patient’s unique biological profile, which can help researchers and healthcare providers better understand the underlying mechanisms of disease.
Advancements in Technology
As technology continues to advance, personalized regenerative medicine will become even more precise and effective, leading to even better patient outcomes.
Conclusion
The concept of personalized regenerative medicine is an exciting new approach to regenerative medicine that has the potential to revolutionize the healthcare industry. Individualized regenerative medicine has the potential to be more effective, improve patient outcomes, lower healthcare costs, and provide better understanding of disease by tailoring treatments to the individual patient. As technology continues to advance, we can expect to see even more exciting developments in this field in the years to come.
You can learn more about regenerative medicine and stem cells by enrolling in our international certification program at www.issca.us.
- Published in Blog
Revolutionizing Neurodegenerative Care: The Advancements in Stem Cell Therapy
MONDAY, 13 MARCH 2023 / PUBLISHED IN BLOG
Neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis, are a group of incurable neurological disorders characterized by the chronic progressive loss of different neuronal subtypes. The conditions are debilitating and affect millions of people worldwide. Despite its increasing prevalence among the ever-increasing aging population, little progress has been made in the coincident immense efforts towards development of therapeutic agents. However, recent advancements in stem cell therapy, including stem cell-derived exosomes, neurotrophic factors (NTFs), and their combination, show promise as potential therapeutic agents in neurodegenerative diseases.
The Promise of Stem Cell Therapy
In recent years, stem cells have emerged as one of the most active research therapeutic tools for many diseases. Stem cells are undifferentiated cells that have the ability to develop into pluripotent stem cells and adult stem cells. All stem cells have the potential for continuous self-renewal, high proliferation, and multidirectional differentiation into various cell types to replace degenerated or dead cells. In the context of neurodegenerative diseases, stem cells can be used to replace lost or damaged neurons, provide neuroprotection, and promote neural repair. These properties make stem cells an attractive option for treating neurodegenerative diseases, as they have the potential to slow or even reverse the progression of these conditions.
Advantages of Stem Cell Therapy
One of the key benefits of stem cell therapy for neurodegenerative diseases is that it offers a non-invasive, minimally-invasive, and non-toxic alternative to traditional treatments. Unlike drugs and surgery, stem cell therapy does not produce adverse side effects and can be administered in a safe and controlled manner. In clinical trials, stem cell therapy has been shown to be effective in reducing symptoms and improving quality of life for patients with neurodegenerative diseases.
Alzheimer’s Disease (AD)
Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the most common form of dementia, affecting approximately 55 million people worldwide. Cognitive impairment is a hallmark of AD. Currently, drug therapies can only delay symptoms, but not relieve disease pathology or progression. Researchers have demonstrated that neurons derived from stem cells can integrate with existing neural networks and repair damaged neurons within the host brain, improving learning and memory deficits. NTFs can improve AD symptoms and provide neuroprotective effects.
Parkinson’s Disease (PD)
The second most common neurodegenerative disorder is Parkinson’s disease (PD). The motor symptoms of PD mainly include rest tremor, rigidity, bradykinesia, and postural instability, while common nonmotor symptoms include neuropsychiatric and sleep disorders as well as sensory and autonomic dysfunction. At present, there is no cure for PD or disease-modifying therapy. It is common for symptom-relief medications to only provide partial relief and elicit side effects such as motor complications, gastrointestinal problems, and neurological issues. In spite of the fact that these treatments do not address the underlying pathology, alternative therapies, especially those based on stem cells and NTFs, are still being pursued intensively.
Huntington’s Disease (HD)
Huntington’s disease (HD) is characterized by motor, cognitive, and psychiatric dysfunctions. The study of multiple possible neurodegenerative mechanisms of HD is currently underway, and this knowledge is expected to contribute to the development of new HD treatments. The abilities of stem cells to rescue or replace the damaged and dying neurons, and to prevent further cell damage and death, make stem cell-based therapies promising for treatment of this neurodegenerative disease.
Amyotrophic Lateral Sclerosis (ALS)
As a neurodegenerative disorder, amyotrophic lateral sclerosis (ALS) involves progressive degeneration of both upper and lower motor
neurons, resulting in palsy and death within 3-5 years of onset. Currently, only two disease-modifying medicines are available, each showing benefit to a limited number of patients. Stem cell-based therapy holds great promise for treating ALS by providing both cell replacement and NTF delivery to target the multiple pathologies. Stem cells available for ALS treatment include NSCs, MSCs, embryonic stem cells, induced pluripotent stem cells, and olfactory ensheathing stem cells.
The Future of Stem Cell Therapy in Neurodegenerative Diseases
While stem cell therapy is still in the early stages of development, it holds enormous promise as a future treatment for neurodegenerative diseases. A number of studies have demonstrated that stem cells and NTFs offer considerable therapeutic potential, especially when they are used together. In addition to replenishing target neurons, stem cells combined with NTFs can produce neurotrophins to improve the microenvironment that promotes nerve repair and regeneration. As research continues, we can expect to see even more exciting advancements in this field, bringing hope to those affected by these debilitating conditions.
Conclusion
Stem cell therapy represents a revolutionary approach to treating neurodegenerative diseases, offering a non-toxic, minimally-invasive alternative to traditional treatments. With ongoing research and development, the potential to improve patient outcomes and quality of life is immense. It’s important to stay informed about the latest developments in stem cell therapy. You can learn more about regenerative medicine and stem cells by enrolling in our international certification program at www.issca.us.
- Published in Blog
New advances in osteoarthritis therapy with stem cells
FRIDAY, 18 NOVEMBER 2022 / PUBLISHED IN BLOG
Osteoarthritis is a rheumatic pathology that damages the articular cartilage. By joining two bones through the joint capsule, the joints are able to move, providing us with functional autonomy. An inner fluid called synovial fluid is usually found within joints, which is produced by the synovial membrane. Articular cartilage covers the ends of the bones that form the joint. As a result of damage to this articular cartilage, pain, stiffness, and functional impairment occur. Osteoarthritis is the most common joint disorder, usually beginning between the ages of 40 and 50, affecting to some degree almost everyone over the age of 80. Typically, osteoarthritis affects the spine, shoulders, fingers, hips, knees, and toe joints.
Potential of Stem Cell Therapies
Stem cell therapies have the potential to treat a broad spectrum of diseases, including osteoarthritis, rhizarthrosis, diabetes, neurodegenerative diseases, spinal cord injuries, and heart disease. By utilizing stem cells, regenerative medicine is capable of repairing tissues in affected areas. The main difference between lipogem therapy and other treatments for osteoarthritis is that lipogem therapy regenerates cartilage, avoids surgery and its sequelae, and improves the quality of life for patients.
Advances in Sports Medicine and Traumatology
The potential for medical treatments with stem cells and their by-products is currently very high. In the field of sports medicine and traumatology, one of the most outstanding advances has been made for the first time in decades recently: Spanish scientists have achieved a degree of tendon regeneration in 100% of injured patients, resulting in a decrease in pain and a return to sport within two months, and just six months after the trial was completed.
A research performed by the Institute of Regenerative Tissue Therapy (ITRT), published by the prestigious American Journal of Sports Medicine, demonstrates how this therapy regenerates chronic lesions in the patellar tendon and opens up a new therapeutic option for this tissue, which was considered impossible to regenerate.
Adipose Tissue-Derived MSCs
In most patients, fat tissue can be harvested minimally invasively (under local or general anesthesia), providing a highly viable MSC population regardless of donor age. Similar to MSCs derived from other tissues, adipose tissue-derived MSCs have regenerative potential. As osteoarthritis is a very common joint disease, and knee osteoarthritis is the most common form, it is necessary to review scientific literature on osteoarthritis treatments with stem cells, like lipogems.
Lipogems Therapy
Lipogems therapy is a novel procedure that enhances the body’s natural ability to heal itself through the innovative power of science and biotechnology. The Lipogems method involves injecting mesenchymal stem cells into the joints. Adipose-derived mesenchymal stem cells have enormous regenerative potential. They also have a regenerative capacity independent of their age. Even older individuals can benefit from this procedure.
Injection of mesenchymal stem cells into the knee, particularly in the early stages of osteoarthritis, can stop the process of inflammation and degeneration, especially in the less advanced stages of the disease. In addition to preventing progressive physical deterioration of the articular cartilage, this treatment contributes significantly to a patient’s well-being and prevents the installation of knee prostheses.
Patellar Tendinopathy: Physiotherapeutic Treatment and Stem Cell Therapy
Injuries to the patellar tendon that connects the kneecap to the tibia are known as patellar tendinopathy or patellar tendinitis. The patellar tendon works with the muscles in the front of the thigh to extend the knee so you can kick, run, and jump. Athletes who perform frequent jumping in their sports, such as basketball and volleyball, are most likely to suffer from patellar tendonitis. However, people who don’t engage in jumping sports may develop patellar tendonitis. Patients with patellar tendinitis usually begin treatment with physical therapy to stretch and strengthen their knee muscles.
Strength Training and Stem Cell Therapy for Tendinopathies
Strength training with eccentric resistance is one of the most common treatments for tendinopathies. Alternatively, it has been demonstrated that bone marrow-derived mesenchymal stem cells (MSCs) can regenerate injured patellar tendons. Within six months of treatment, it has been observed that the structure of this tissue – which is always difficult to treat – is restored, reaching a regeneration of 40% in all injured persons, with a gradual improvement that eventually becomes complete.
Combination Therapies for Patellar Tendinopathy
It has been found that traditional management methods, including isometric or eccentric exercises, shock wave therapy, and even surgery, are not effective. As part of a rehabilitation program in chronic patellar tendinopathy, autologous expanded bone marrow mesenchymal stem cells (BM-MSC) or leukocyte-poor platelet-rich plasma (Lp-PRP) may be effective in reducing pain and improving activity levels. Traditional management, which includes isometric or eccentric exercises, shock wave therapy, and even surgery, has limited success. A combination of autologous expanded bone marrow mesenchymal stem cells (BM-MSCs) and leukocyte-poor platelet-rich plasma (Lp-PRP) and rehabilitation may reduce pain and improve activity levels in active participants with chronic patellar tendinopathy.
To learn more about stem cells, cellular therapies, and keep up to date with all the information about regenerative medicine and its advances, sign up for our international certification in regenerative medicine at www.issca.us.
- Published in Blog
ISSCA Members to Present in the XXV Congreso Internacional de Medicina, Cirugia Estética y Obesidad
The XXV Congreso Internacional de Medicina, Cirugia Estética y Obesidad will take place in CDMX, México on July 13,14 and 15, 2022. The International Society for Stem Cell Application (ISSCA) will be actively taking part in the congress. The ISSCA is a multidisciplinary community of physicians and scientists with a mission to advance the science, technology, and practice of regenerative medicine to treat diseases and lessen human suffering through science, technology, and regenerative medicine. Several ISSCA members will be presenting or giving demonstrations on the latest protocols and technologies in regenerative medicine.
- Benito Novas, the managing director of the ISSCA from the USA, will give a talk about Digital Marketing in Cash-Based Practices. Benito Novas is a global entrepreneur, manager, and keynote speaker, who specializes in marketing focused on biotechnology, life sciences, and healthcare development. He has served as the director of the ISSCA since 2016. His published books in Aesthetic Practice and Digital Marketing can be found here. In his presentation this July, he will share his visionary approach to healthcare management and regenerative medicine. Congress attendees will have the opportunity to learn why doctors must use digital marketing strategies to grow a successful practice. Benito Novas will provide tips to attendees on how to capitalize on social media trends to grow practice influence.
- Dr. Maritza Novas, the ISSCA director of education from the USA, will talk about Allogeneic Therapies and Stromal Cell Exosomes. The use of allogeneic therapy is one of the most attractive alternatives to autologous products and is of utmost interest to researchers in recent years. Exosomes serve as mediators for cell-to-cell communication and can be used as cell-free therapeutics for their special characteristics. Dr. Maritza Novas has been in aesthetic and anti-aging medicine since 2001. She is globally recognized for her work in regenerative medicine and dedicated service in education.
- Dr. Silvina Pastrana, the Argentina chapter director of the ISSCA from Argentina, will present on Fundamentals of Cellular Therapies and Mesenchymal Stem Cells (MSC). Dr. Pastrana heads a staff of medical specialists in orthopedics, rheumatology, medical clinic, and cosmetic surgery, performing procedures that incorporate stem cell therapies. She has been serving as a staff surgeon for the Hospital Dr. Prof. Luis Güemes for 21 years.
Besides the above presentations, look forward to sessions in the practical portion of the congress, where the following ISSCA members will show the latest protocols and technologies in regenerative medicine:
- Dr. Julio Ferreira (Argentina), Cosmetic Surgery / Aesthetic Medicine
- Dr. Andrea Lapeire (Argentina), Aesthetic Medicine
- Dr. Maritza Novas (USA), ISSCA Director of Education in the USA
- Dr. Silvina Pastrana (Argentina), Chapter Director of ISSCA in Argentina
The ISSCA members are the leaders in setting standards and promoting excellence in the field of regenerative medicine, related education, certification, research, and publications. The Global Stem Cells Groups (GSCG) is a group of companies, including the ISSCA and other members, dedicated to facilitating stem cell research and medicine. Making the benefits of stem cell medicine a reality for both doctors and patients worldwide is the goal of the GSCG. To learn more, visit our sites at the ISSCA and the GSCG.
- Published in News
Global Stem Cells Group Announces Partnership with Bioscience Cell Factory
Just earlier this week, Global Stem Cells Group has signed a historic agreement with a company known as Bioscience Cell Factory– this Dubai-based healthcare company will allow GSCG to act as their representatives operating in both the Middle East and Latin America. Through the acquisition of proprietary branding rights Global Stem Cells Groups will become committed to promote the widespread use of cellular therapy treatments that utilize Mesenchymal Stem Cells (MSCs).
This partnership is groundbreaking in nature, and promises to lead to a wide proliferation of cellular therapies in both the Middle East and Latin America, two regions that are rapidly developing, with a constantly-advancing standard of medical care. Global Stem Cells Group will be clinically equipped with the highest standards and quality procedures as set forth by the Bioscience Cell Factory, resulting in nothing but the best treatment methods available for patients around the world.
“I’m extremely excited about this partnership,” Said Benito Novas, CEO of the Global Stem Cells Group, “Bioscience Cell Factory is one of the most professional and scientifically-focused teams that I’ve ever had the pleasure of working with– I am looking forward to the start of what will be an extremely beneficial professional relationship that will provide our global reach with the quality of Bioscience’s laboratory,”
Indeed, the two firms are also announcing plans to do research together into the nature of adult Mesenchymal Stem Cells, and the benefits that they hold for the medical field. Through the training of physicians and the handling of cell samples in their laboratory, there are high hopes for the advancement of the field of regenerative medicine research. As one of the representatives of the Bioscience Cell Factory abroad, Global Stem Cells Group will further its goal of being a global leader in the regenerative medicine field.
About Bioscience Cell Factory
Bioscience Clinic is a global healthcare company that is based in Dubai, committed to the running of a laboratory for the banking and use of all sorts of allogeneic and autologous cellular products. Through the proliferation of cellular therapies throughout the world, Bioscience Clinic hopes to advance treatment options for some debilitating diseases that current medical science has been largely unable to target the root causes of.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in News
